Clinical utility of immunoglobulin heavy chain gene rearrangement identification for tumour cell detection in multiple myeloma

British Journal of Haematology

Volumn 103, Issue 4, 1998, Pages 1145-1151

  Swedin, Agneta ^a   Lenhoff, Stig ^a   Olofsson, Tor ^a   Thuresson, Britt ^a   Westin, Jan ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

ASO PCR; IgH; MRD; Myeloma

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; MELPHALAN; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; FEMALE; GENE REARRANGEMENT; GENETIC ANALYSIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKAPHERESIS; MALE; MULTIPLE MYELOMA; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; FEMALE; GENE REARRANGEMENT, B-LYMPHOCYTE, HEAVY CHAIN; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEOPLASM, RESIDUAL; OLIGONUCLEOTIDE PROBES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; TREATMENT OUTCOME;

EID: 0032411236     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.01075.x     Document Type: Article

References (25)

1. Alexanian, R. & Dimopoulos, M. (1994) The treatment of multiple myeloma. New England Journal of Medicine, 330, 484-489.
2. Arnold, A., Cossman, J., Bakhshi, A., Jaffe, E.S., Waldmann, T.A. & Korsmeyer, S.J. (1983) Immunoglobulin gene rearrangements as unique clonal markers in human lymphoid neoplasms. New England Journal of Medicine, 309, 1593-1599.
3. Attal, M., Harousseau, J-L., Stoppa, A-M., Sotto, J-J., Fuzibet, J-G., Rossi, J-F., Casassus, P., Maisonneuve, H., Facon, T., Ifrah, N., Payen, C. & Bataille, R. (1996) A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. New England Journal of Medicine, 335, 91-97.
4. Barlogie, B. & Gahrton, G. (1991) Bone marrow transplantation in multiple myeloma. Bone Marrow Transplantation, 7, 71-79.
5. Billadeau, D., Blackstadt, M., Greipp, P., Kyle, R.A., Oken, M.M., Kay, N. & Van, N.B. (1991) Analysis of B-lymphoid malignancies using allele-specific polymerase chain reaction: a technique for sequential quantitation of residual disease. Blood, 78, 3021-3029.
6. Billadeau, D., Prosper, F., Verfaillie, C., Weisdorf, D. & van Ness, B. (1997) Sequential analysis of bone marrow and peripheral blood after stem cell transplantation for myeloma shows disparate tumor involvement. Leukemia, 11, 1565-1570.
7. Bird, J.M., Bloxham, D., Samson, D., Narcus, R.E., Russell, N.H., Kelsey, S.M., Newland, A.C. & Apperley, J.F. (1994) Molecular detection of clonally rearranged cells in peripheral blood progenitor cell harvests from multiple myeloma patients. British Journal of Haematology, 88, 110-116.
8. Bird, J.M., Russell, N.H. & Samson, D. (1993) Minimal residual disease after bone marrow transplantation for multiple myeloma: evidence for cure in long-term survivors. Bone Marrow Transplantation, 12, 651-654.
9. Björkstrand, B., Svensson, H., Ljungman, P., Apperley, J., Goldschmidt, H., Remes, K., Alegre, A., Marcus, R., Carlson, K., Coser, P., Sureda, A., Barbui, T., Goldstone, A.H., Bladé, J., Volin, L., Boogaerts, M. Lenhoff, S., Majolino, I., Samson, D., de Laurenzi, A., Caballero, D. & Gahrton, G. (1997) 2522 autotransplants in multiple myeloma: a registry study from the European Group for Blood and Marrow Transplantation (EBMT). Blood, 90, (Suppl. 1), Abstract 1862.
10. Corradini, P., Voena, C., Astolfi, M., Ladetto, M., Tarella, C., Boccadoro, M. & Pileri, A. (1995) High-dose sequential chemoradiotherapy in multiple myeloma: residual tumor cells are detectable in bone marrow and peripheral blood cell harvests and after autografting. Blood, 85, 1596-1602.
11. Deane, M. & Norton, J.D. (1991) Immunoglobulin gene 'fingerprinting': an approach to analysis of B lymphoid clonality in lymphoproliferative disorders. British Journal of Haematology, 77, 274-281.
12. Gahrton, G., Tura, S., Ljungman, P., Belanger, C., Brandt, L., Cavo, M., Facon, T., Granena, A., Gore, M., Gratwohl, A., Löwenberg, B., Nikoskelainen, J., Reiffers, J., Samson, D., Verdonck, L. & Volin, L., for the European Group for Bone Marrow Transplantation (1991) Allogeneic bone marrow transplantation in multiple myeloma. New England Journal of Medicine, 325, 1267-1273.
13. + stem cells do not contain clonal myeloma cells. Blood, 86, 381-389.
14. Goulden, N.J., Knechtli, C.J., Garland, R.J., Langlands, K., Hancock, J.P., Potter, M.N., Steward, C.G. & Oakhill, A. (1998) Minimal residual disease analysis for the prediction of relapse in children with standard-risk acute lymphoblastic leukaemia. British Journal of Haematology, 100, 235-244.
15. Gregory, W.M., Richards, M.A. & Malpas, J.S. (1992) Combination chemotherapy versus melphalan and prednisolone in the treatment of multiple myeloma: an overview of published trials. Journal of Clinical Oncology, 10, 334-342.
16. Hjorth, M., Hellquist, L., Holmberg, E., Magnusson, B., Rödjer, S., & Westin, J. (1990) Initial treatment in multiple myeloma: no advantage of multidrug chemotherapy over melphalan-prednisone. British Journal of Haematology, 74, 185-191.
17. Jacquy, C., Delepaut, B., van Daele, S., Vaerman, J.L., Zenebergh, A., Brichard, B., Vermeylen, C., Cornu, G. & Martiat, P. (1997) A prospective study of minimal residual disease in childhood B-lineage acute lymphoblastic leukaemia: MRD level at the end of induction is a strong predictive factor of relapse. British Journal of Haematology, 98, 140-146.
18. Provan, D., Bartlett-Pandite, L., Zwicky, C., Neuberg, D., Maddocks, A., Corradini, P., Soiffer, R., Ritz, J., Nadler, L.M. & Gribben, J.G. (1996) Eradication of polymerase chain reaction-detectable chronic lymphocytic leukemia cells is associated with improved outcome after bone marrow transplantation. Blood, 88, 2228-2235.
19. Sakai, A., Kawano, M.M., Tanabe, O. & Kuramoto, A. (1993) A possible mechanism of inability of immunoglobulin heavy-chain production in Bence-Jones type myeloma cells. International Journal of Hematology, 59, 31-40.
20. + cells in the blood of patients with multiple myeloma express CD19 and IgH mRNA and have patient-specific IgH VDJ gene rearrangements. Blood, 89, 1824-1833.
21. + blood cells in multiple myeloma. British Journal of Haematology, 96, 403-411.
22. Vescio, R.A., Hong, C.H., Cao, J., Kim, A., Schiller, G.J., Lichtenstein, A.K., Berenson, R.J. & Berenson, J.R. (1994) The hematopoietic stem cell antigen, CD34, is not expressed on the malignant cells in multiple myeloma. Blood, 84, 3283-3290.
23. Witzig, T.E., Gertz, M., Lust, J., Kyle, R. & Greipp, P. (1995a) Serial studies of peripheral blood myeloma cells in patients with multiple myeloma: when is the optimal time for stem cell harvest? Leukemia and Lymphoma, 19, 417-422.
24. Witzig, T.E., Gertz, M.A., Pineda, A.A., Kyle, R.A. & Greipp, P.R. (1995b) Detection of monoclonal plasma cells in the peripheral blood stem cell harvests of patients with multiple myeloma. British Journal of Haematology, 89, 640-642.
25. Zwicky, C.S., Maddocks, A.B., Andersen, N., Gribben, J.G. (1996) Eradication of polymerase chain reaction detectable immunoglobulin gene rearrangements in non-Hodgkin's lymphoma is associated with decreased relapse after autologous bone marrow transplantation. Blood, 88, 3314-3322.